Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.

Garg AV, Amatya N, Chen K, Cruz JA, Grover P, Whibley N, Conti HR, Hernandez Mir G, Sirakova T, Childs EC, Smithgall TE, Biswas PS, Kolls JK, McGeachy MJ, Kolattukudy PE, Gaffen SL.

Immunity. 2015 Sep 15;43(3):475-87. doi: 10.1016/j.immuni.2015.07.021. Epub 2015 Aug 25.

2.

Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.

Ferreira MC, Whibley N, Mamo AJ, Siebenlist U, Chan YR, Gaffen SL.

Infect Immun. 2014 Mar;82(3):1030-5. doi: 10.1128/IAI.01389-13. Epub 2013 Dec 16.

3.

MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.

Monin L, Gudjonsson JE, Childs EE, Amatya N, Xing X, Verma AH, Coleman BM, Garg AV, Killeen M, Mathers A, Ward NL, Gaffen SL.

J Immunol. 2017 Jan 15;198(2):767-775. doi: 10.4049/jimmunol.1601551. Epub 2016 Dec 5.

4.

The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.

Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X.

Nat Immunol. 2007 Mar;8(3):247-56. Epub 2007 Feb 4.

PMID:
17277779
5.

Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection.

Liu Z, Reba S, Chen WD, Porwal SK, Boom WH, Petersen RB, Rojas R, Viswanathan R, Devireddy L.

J Exp Med. 2014 Jun 2;211(6):1197-213. doi: 10.1084/jem.20132629. Epub 2014 May 26.

6.

MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A.

Ruiz-Romeu E, Ferran M, Giménez-Arnau A, Bugara B, Lipert B, Jura J, Florencia EF, Prens EP, Celada A, Pujol RM, Santamaria-Babí LF.

J Invest Dermatol. 2016 Aug;136(8):1599-607. doi: 10.1016/j.jid.2016.04.030. Epub 2016 May 12.

7.

Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.

Conti HR, Whibley N, Coleman BM, Garg AV, Jaycox JR, Gaffen SL.

PLoS One. 2015 Apr 7;10(4):e0122807. doi: 10.1371/journal.pone.0122807. eCollection 2015.

8.

DNA element downstream of the κB site in the Lcn2 promoter is required for transcriptional activation by IκBζ and NF-κB p50.

Kohda A, Yamazaki S, Sumimoto H.

Genes Cells. 2014 Aug;19(8):620-8. doi: 10.1111/gtc.12162. Epub 2014 Jun 20.

9.

RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway.

Lyu JH, Park DW, Huang B, Kang SH, Lee SJ, Lee C, Bae YS, Lee JG, Baek SH.

J Cell Biochem. 2015 Feb;116(2):260-7. doi: 10.1002/jcb.24964.

PMID:
25187114
10.

The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.

Bulek K, Liu C, Swaidani S, Wang L, Page RC, Gulen MF, Herjan T, Abbadi A, Qian W, Sun D, Lauer M, Hascall V, Misra S, Chance MR, Aronica M, Hamilton T, Li X.

Nat Immunol. 2011 Aug 7;12(9):844-52. doi: 10.1038/ni.2080.

11.

Monocyte Chemotactic Protein-induced Protein 1 and 4 Form a Complex but Act Independently in Regulation of Interleukin-6 mRNA Degradation.

Huang S, Liu S, Fu JJ, Tony Wang T, Yao X, Kumar A, Liu G, Fu M.

J Biol Chem. 2015 Aug 21;290(34):20782-92. doi: 10.1074/jbc.M114.635870. Epub 2015 Jul 1.

12.

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T.

Nat Immunol. 2011 Aug 7;12(9):853-60. doi: 10.1038/ni.2081.

13.

IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16.

Xie S, Li J, Wang JH, Wu Q, Yang P, Hsu HC, Smythies LE, Mountz JD.

J Immunol. 2010 Mar 1;184(5):2289-96. doi: 10.4049/jimmunol.0903133. Epub 2010 Feb 5.

14.

A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.

Liu C, Swaidani S, Qian W, Kang Z, Sun P, Han Y, Wang C, Gulen MF, Yin W, Zhang C, Fox PL, Aronica M, Hamilton TA, Misra S, Deng J, Li X.

Sci Signal. 2011 Nov 1;4(197):ra72. doi: 10.1126/scisignal.2001843.

15.

IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Conti HR, Gaffen SL.

J Immunol. 2015 Aug 1;195(3):780-8. doi: 10.4049/jimmunol.1500909. Review.

16.

The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression.

Hörber S, Hildebrand DG, Lieb WS, Lorscheid S, Hailfinger S, Schulze-Osthoff K, Essmann F.

J Biol Chem. 2016 Jun 10;291(24):12851-61. doi: 10.1074/jbc.M116.718825. Epub 2016 Apr 18.

17.

Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.

Berard JL, Zarruk JG, Arbour N, Prat A, Yong VW, Jacques FH, Akira S, David S.

Glia. 2012 Jul;60(7):1145-59. doi: 10.1002/glia.22342. Epub 2012 Apr 12.

PMID:
22499213
18.

mRNA degradation by the endoribonuclease Regnase-1/ZC3H12a/MCPIP-1.

Uehata T, Akira S.

Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):708-13. doi: 10.1016/j.bbagrm.2013.03.001. Epub 2013 Mar 13. Review.

PMID:
23500036
19.

Recent advances in the IL-17 cytokine family.

Gaffen SL.

Curr Opin Immunol. 2011 Oct;23(5):613-9. doi: 10.1016/j.coi.2011.07.006. Epub 2011 Aug 16. Review.

20.

Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.

Kumar P, Monin L, Castillo P, Elsegeiny W, Horne W, Eddens T, Vikram A, Good M, Schoenborn AA, Bibby K, Montelaro RC, Metzger DW, Gulati AS, Kolls JK.

Immunity. 2016 Mar 15;44(3):659-671. doi: 10.1016/j.immuni.2016.02.007.

Supplemental Content

Support Center